Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Where Wild Things Grow: Immediate and Long-term Impact of Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth in School, Health Care and Leisure Settings in Agder

NCT07203469 is registered in ClinicalTrials.gov with Sorlandet Hospital HF as lead sponsor.

NCT NCT07203469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07203469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Where Wild Things Grow: Immediate and Long-term Impact of Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth in School, Health Care and Leisure Settings in Agder
Lead sponsor
Sorlandet Hospital HF
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2025
Completion date
June 15, 2027
Enrollment
240 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adhd - attention deficit disorder with hyperactivity, autism, health-related quality-of-life, heart rate variability (hrv), neurodevelopmental outcomes, tourette syndrome